Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers

Published:2015-05-18 Issue:3 Volume:57 Page:182-191
ISSN:0004-8380
Container-title:Australasian Journal of Dermatology
language:en
Short-container-title:Australasian Journal of Dermatology

Author:

Hughes Charlotte FM¹²,Newland Kate³,McCormack Christopher²³,Lade Stephen⁴,Prince H Miles¹²

Affiliation:

1. Division of Haematology and Cancer Medicine; Peter MacCallum Cancer Centre; Melbourne Victoria Australia

2. Sir Peter MacCallum Department of Oncology; University of Melbourne; Melbourne Victoria Australia

3. Department of Dermatology; St Vincent's Hospital Department of Medicine; Melbourne Victoria Australia

4. Division of Pathology; Peter MacCallum Cancer Centre; Melbourne Victoria Australia

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajd.12349/fullpdf

Reference96 articles.

1. WHO-EORTC classification for cutaneous lymphomas;Willemze;Blood,2005

2. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002;Criscione;Arch. Dermatol.,2007

3. . Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality;Weinstock;Am. J. Public Health,1999

4. Review of the treatment of mycosis fungoides and Sezary syndrome: a stage-based approach;Horwitz;J. Natl Compr. Canc. Netw.,2008

5. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome;Trautinger;Eur. J. Cancer,2006

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mogamulizumab and Concomitant Hypofractionated Low-Dose Total Skin Electron Beam Therapy (2 × 4 Gy) in Cutaneous T-Cell Lymphoma: Proof of Principle, Report of Two Cases;Current Oncology;2024-09-13

2. A case report of refractory advanced-stage mycosis fungoides: successful treatment and improved patient quality of life with mogamulizumab;Therapeutic Advances in Hematology;2024-01

3. Mature T-cell and NK-cell neoplasms: Group 1;Atlas of Hematopathology with 100 Case Studies;2024

4. mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy;Cancers;2023-09-04

5. Healthcare Provider Experience in Diagnosing and Treating Cutaneous T-Cell Lymphoma;Dermatology and Therapy;2023-02-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3